Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about OncoBeta GmbH
Recent news which mentions OncoBeta GmbH
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
July 11, 2023
Tickers
EPIC
Tags
Health
Science
Medical
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Squamous Cell Carcinoma
Basal Cell Carcinoma
Rhenium/188
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Health
Science
Skin Cancer Therapy
From
PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
December 22, 2022
Tags
OncoBeta GmbH
Research
Bavaria
From
PRLog
'Spot Detective' – Check your spots this summer
November 22, 2022
Tags
Sydney
Non/melanoma skin cancer
Beauty
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Skin Cancer Therapy
Germany
Medical
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Non/melanoma skin cancer
Rostock
OncoBeta GmbH
From
PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
Health
Perth
Science
From
PRLog
OncoBeta launches International Registry for Non-Melanoma Skin Cancer
November 24, 2021
Tags
Munich
Real/world patient data
Sydney
From
PRLog
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.